Order Article Reprints

Kawaratani H, Kondo Y, Tatsumi R, Kawabe N, Tanabe N, Sakamaki A, Okumoto K, Uchida Y, Endo K, Kawaguchi T, et al. Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study. Journal of Clinical Medicine. 2022; 11(6):1571. https://doi.org/10.3390/jcm11061571

Kawaratani, Hideto, Yasuteru Kondo, Ryoji Tatsumi, Naoto Kawabe, Norikazu Tanabe, Akira Sakamaki, Kazuo Okumoto, Yoshihito Uchida, Kei Endo, Takumi Kawaguchi, and et al. 2022. "Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study" Journal of Clinical Medicine 11, no. 6: 1571. https://doi.org/10.3390/jcm11061571

Kawaratani, H., Kondo, Y., Tatsumi, R., Kawabe, N., Tanabe, N., Sakamaki, A., Okumoto, K., Uchida, Y., Endo, K., Kawaguchi, T., Oikawa, T., Ishizu, Y., Hige, S., Takami, T., Terai, S., Ueno, Y., Mochida, S., Takikawa, Y., Torimura, T., ... Yoshiji, H. (2022). Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study. Journal of Clinical Medicine, 11(6), 1571. https://doi.org/10.3390/jcm11061571